369 related articles for article (PubMed ID: 23784006)
1. B7-H5 costimulates human T cells via CD28H.
Zhu Y; Yao S; Iliopoulou BP; Han X; Augustine MM; Xu H; Phennicie RT; Flies SJ; Broadwater M; Ruff W; Taube JM; Zheng L; Luo L; Zhu G; Chen J; Chen L
Nat Commun; 2013; 4():2043. PubMed ID: 23784006
[TBL] [Abstract][Full Text] [Related]
2. Phenotypical and potential functional characteristics of different immune cells expressing CD28H/B7-H5 and their relationship with cancer prognosis.
Zhong C; Lang Q; Yu J; Wu S; Xu F; Tian Y
Clin Exp Immunol; 2020 Apr; 200(1):12-21. PubMed ID: 31901178
[TBL] [Abstract][Full Text] [Related]
3. B7-H5/CD28H is a co-stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma.
Chen Q; Wang J; Chen W; Zhang Q; Wei T; Zhou Y; Xu X; Bai X; Liang T
Cancer Sci; 2019 Feb; 110(2):530-539. PubMed ID: 30548441
[TBL] [Abstract][Full Text] [Related]
4. CD28H expression identifies resident memory CD8 + T cells with less cytotoxicity in human peripheral tissues and cancers.
Tian Y; Sun Y; Gao F; Koenig MR; Sunderland A; Fujiwara Y; Torphy RJ; Chen L; Edil BH; Schulick RD; Zhu Y
Oncoimmunology; 2019; 8(2):e1538440. PubMed ID: 30713797
[TBL] [Abstract][Full Text] [Related]
5. CD28 Homolog Is a Strong Activator of Natural Killer Cells for Lysis of B7H7
Zhuang X; Long EO
Cancer Immunol Res; 2019 Jun; 7(6):939-951. PubMed ID: 31018957
[TBL] [Abstract][Full Text] [Related]
6. B7-H7 (HHLA2) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling.
Rieder SA; Wang J; White N; Qadri A; Menard C; Stephens G; Karnell JL; Rudd CE; Kolbeck R
Cell Mol Immunol; 2021 Jun; 18(6):1503-1511. PubMed ID: 32005952
[TBL] [Abstract][Full Text] [Related]
7. K12/SECTM1, an interferon-γ regulated molecule, synergizes with CD28 to costimulate human T cell proliferation.
Wang T; Huang C; Lopez-Coral A; Slentz-Kesler KA; Xiao M; Wherry EJ; Kaufman RE
J Leukoc Biol; 2012 Mar; 91(3):449-59. PubMed ID: 22184754
[TBL] [Abstract][Full Text] [Related]
8. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells.
Tseng SY; Otsuji M; Gorski K; Huang X; Slansky JE; Pai SI; Shalabi A; Shin T; Pardoll DM; Tsuchiya H
J Exp Med; 2001 Apr; 193(7):839-46. PubMed ID: 11283156
[TBL] [Abstract][Full Text] [Related]
9. BTNL8, a butyrophilin-like molecule that costimulates the primary immune response.
Chapoval AI; Smithson G; Brunick L; Mesri M; Boldog FL; Andrew D; Khramtsov NV; Feshchenko EA; Starling GC; Mezes PS
Mol Immunol; 2013 Dec; 56(4):819-28. PubMed ID: 24036152
[TBL] [Abstract][Full Text] [Related]
10. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.
Freeman GJ; Gribben JG; Boussiotis VA; Ng JW; Restivo VA; Lombard LA; Gray GS; Nadler LM
Science; 1993 Nov; 262(5135):909-11. PubMed ID: 7694363
[TBL] [Abstract][Full Text] [Related]
11. The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.
Janakiram M; Shah UA; Liu W; Zhao A; Schoenberg MP; Zang X
Immunol Rev; 2017 Mar; 276(1):26-39. PubMed ID: 28258693
[TBL] [Abstract][Full Text] [Related]
12. A retro-inverso peptide mimic of CD28 encompassing the MYPPPY motif adopts a polyproline type II helix and inhibits encephalitogenic T cells in vitro.
Srinivasan M; Wardrop RM; Gienapp IE; Stuckman SS; Whitacre CC; Kaumaya PT
J Immunol; 2001 Jul; 167(1):578-85. PubMed ID: 11418697
[TBL] [Abstract][Full Text] [Related]
13. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function.
Tamura H; Dong H; Zhu G; Sica GL; Flies DB; Tamada K; Chen L
Blood; 2001 Mar; 97(6):1809-16. PubMed ID: 11238124
[TBL] [Abstract][Full Text] [Related]
14. B7-h2 is a costimulatory ligand for CD28 in human.
Yao S; Zhu Y; Zhu G; Augustine M; Zheng L; Goode DJ; Broadwater M; Ruff W; Flies S; Xu H; Flies D; Luo L; Wang S; Chen L
Immunity; 2011 May; 34(5):729-40. PubMed ID: 21530327
[TBL] [Abstract][Full Text] [Related]
15. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
Wingren AG; Parra E; Varga M; Kalland T; Sjogren HO; Hedlund G; Dohlsten M
Crit Rev Immunol; 2017; 37(2-6):463-481. PubMed ID: 29773030
[TBL] [Abstract][Full Text] [Related]
16. Dynamic equilibrium of B7-1 dimers and monomers differentially affects immunological synapse formation and T cell activation in response to TCR/CD28 stimulation.
Bhatia S; Sun K; Almo SC; Nathenson SG; Hodes RJ
J Immunol; 2010 Feb; 184(4):1821-8. PubMed ID: 20065109
[TBL] [Abstract][Full Text] [Related]
17. Phenotype and tissue distribution of CD28H
Crespo J; Vatan L; Maj T; Liu R; Kryczek I; Zou W
Oncoimmunology; 2017; 6(12):e1362529. PubMed ID: 29209568
[TBL] [Abstract][Full Text] [Related]
18. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
[TBL] [Abstract][Full Text] [Related]
19. B7-H7 Is Inducible on T Cells to Regulate Their Immune Response and Serves as a Marker for Exhaustion.
Luu K; Schwarz H; Lundqvist A
Front Immunol; 2021; 12():682627. PubMed ID: 34140952
[TBL] [Abstract][Full Text] [Related]
20. Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells.
Vandenberghe P; Freeman GJ; Nadler LM; Fletcher MC; Kamoun M; Turka LA; Ledbetter JA; Thompson CB; June CH
J Exp Med; 1992 Apr; 175(4):951-60. PubMed ID: 1372649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
